The Pathophysiology of IgAN and Use of Immunomodulating Therapies

An expert nephrologist provides an overview of the pathophysiology of IgAN before discussing new immunomodulating therapies in clinical trials.

Related Keywords

Milan ,Lombardia ,Italy ,China ,Chee Kay Cheung ,European Renal Association ,Visionary Study ,Wigan ,Nephropathy ,Pathophysiology ,Pro Inflammatory Effect ,Mesangial Cell Activation ,B Cell ,Baff ,April ,Complement Inhibition ,Atacicept ,Monoclonal Antibody ,Clinical Trial ,Naiveb Cell ,Origin Trial ,